# EGb 761 in the Syndrome of MCI With Concomitant CVD

> **NCT04525144** · PHASE2 · RECRUITING · sponsor: **National Neuroscience Institute** · enrollment: 134 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Cerebrovascular Disease

## Interventions

- **DRUG:** Tebonin Forte

## Key facts

- **NCT ID:** NCT04525144
- **Lead sponsor:** National Neuroscience Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-26
- **Primary completion:** 2025-12
- **Final completion:** 2026-11
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2022-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04525144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04525144, "EGb 761 in the Syndrome of MCI With Concomitant CVD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04525144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*